Anti-FATP2 antibody
Specifications
| Product Cat#: | AB-06-1671 |
| Product type: | Primary antibody |
| Antigen: | FATP2 |
| Immunogen: | Recombinant protein |
| Species immunized: | Mouse |
| Isotype: | IgG1 |
| Applications: | Western Blot (1:400-1:2000); Immunohistochemistry (1:50-1:200) |
| Reactivity: | Human |
| Clonality (clone number): | Monoclonal (A9-B3) |
| Form: | Liquid |
| Buffer: | 1*TBS (pH7.4), 1% BSA; 40% Glycerol. Preservative: 0.05% Sodium Azide. |
| Concentration: | 1 mg/ml |
| Purity: | Protein A affinity purified |
| Storage: | Aliquot and freeze at -20℃. Avoid multiple freeze/thaw cycles. |
| Alternative names: | ACSVL1 antibody |
| FACVL1 antibody | |
| FATP2 antibody | |
| FATP-2 antibody | |
| FATP2 antibody | |
| Fatty acid coenzyme A ligase, very long chain 1 antibody | |
| Fatty acid transport protein 2 antibody | |
| Fatty-acid-coenzyme A ligase antibody | |
| HFACVL1 antibody | |
| HsT 17226 antibody | |
| Long chain fatty acid CoA ligase antibody | |
| Long-chain-fatty-acidCoA ligase antibody | |
| S27A2_HUMAN antibody | |
| Slc27a2 antibody | |
| Solute carrier family 27 (fatty acid transporter), member 2 antibody | |
| Solute carrier family 27 member 2 antibody | |
| THCA CoA ligase antibody | |
| THCA-CoA ligase antibody | |
| Very long chain acyl CoA synthetase antibody | |
| Very long chain fatty acid CoA ligase antibody | |
| Very long chain fatty acid coenzyme A ligase 1 antibody | |
| Very long-chain 1 antibody | |
| Very long-chain acyl-CoA synthetase antibody | |
| Very long-chain-fatty-acid-CoA ligase antibody | |
| VLACS antibody | |
| VLCS antibody |
Show More
Target information
Acyl-CoA synthetase probably involved in bile acid metabolism. Proposed to activate C27 precursors of bile acids to their CoA thioesters derivatives before side chain cleavage via peroxisomal beta-oxidation occurs. In vitro, activates 3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholestanate (THCA), the C27 precursor of cholic acid deriving from the de novo synthesis from cholesterol. Does not utilize C24 bile acids as substrates. In vitro, also activates long- and branched-chain fatty acids and may have additional roles in fatty acid metabolism. May be involved in translocation of long-chain fatty acids (LFCA) across membranes (By similarity).
Provider
Erpantech Laboratory